Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
36 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Arena Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Arena Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Arena Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Arena Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Arena Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Arena Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Arena Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Arena Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Arena Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Arena Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Arena Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Arena Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Arena Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Arena Pharmaceuticals, Inc. Snapshot 5 Arena Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Arena Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Arena Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Arena Pharmaceuticals, Inc. - Pipeline Products Glance 12 Arena Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12 Phase I Products/Combination Treatment Modalities 12 Arena Pharmaceuticals, Inc. - Early Stage Pipeline Products 13 Discovery Products/Combination Treatment Modalities 13 Arena Pharmaceuticals, Inc. - Drug Profiles 14 APD-334 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 APD-371 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 APD-668 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 APD-811 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 temanogrel hydrochloride 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 APD-597 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Arena Pharmaceuticals, Inc. - Pipeline Analysis 21 Arena Pharmaceuticals, Inc. - Pipeline Products by Target 21 Arena Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 22 Arena Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 23 Arena Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 24 Arena Pharmaceuticals, Inc. - Recent Pipeline Updates 25 Arena Pharmaceuticals, Inc. - Dormant Projects 27 Arena Pharmaceuticals, Inc. - Discontinued Pipeline Products 28 Discontinued Pipeline Product Profiles 28 APD-597 28 nelotanserin 28 Arena Pharmaceuticals, Inc. - Company Statement 29 Arena Pharmaceuticals, Inc. - Locations And Subsidiaries 34 Head Office 34 Other Locations & Subsidiaries 34 Appendix 35 Methodology 35 Coverage 35 Secondary Research 35 Primary Research 35 Expert Panel Validation 35 Contact Us 36 Disclaimer 36
List of Tables Arena Pharmaceuticals, Inc., Key Information 5 Arena Pharmaceuticals, Inc., Key Facts 5 Arena Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 Arena Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 8 Arena Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 9 Arena Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 10 Arena Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11 Arena Pharmaceuticals, Inc. - Phase I, 2014 12 Arena Pharmaceuticals, Inc. - Discovery, 2014 13 Arena Pharmaceuticals, Inc. - Pipeline by Target, 2014 21 Arena Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 22 Arena Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 23 Arena Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 24 Arena Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 25 Arena Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 27 Arena Pharmaceuticals, Inc. - Discontinued Pipeline Products, 2014 28 Arena Pharmaceuticals, Inc., Subsidiaries 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.